Xilio Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Xilio Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q2 2024.
  • Xilio Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 44M shares, a 59.7% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 44M +16.4M +59.7% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 34.5M +7.03M +25.6% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 27.6M +182K +0.66% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 27.5M +122K +0.44% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 27.5M +127K +0.46% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 27.4M +63.3K +0.23% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 27.4M +67.1K +0.25% Dec 31, 2022 10-K 2024-04-01
Q3 2022 27.4M +26.6M +3418% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 27.4M Jun 30, 2022 10-Q 2022-08-09
Q1 2022 27.4M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 27.4M +26.7M +3865% Dec 31, 2021 10-K 2023-03-02
Q3 2021 779K Sep 30, 2021 10-Q 2021-12-02
Q4 2020 690K Dec 31, 2020 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.